Barbara Leyman
Fortuna: 46 943 $ al 31/05/2026
Fortuna: 46 943 $ al 31/05/2026
Barbara Leyman worked as Senior Investment Manager at Limburgse Reconversie Maatschappij NV from 2014 to 2017.
Former jobs include Non-Executive Director at Apitope International NV, Director at Amakem NV, Director at Complix NV, Chief Business Development Officer at Sutro Biopharma, Inc. from 2024 to 2025, and Senior Vice President-Corporate Development at Breeze Bio, Inc. Education includes a doctorate from Imperial College London and a graduate degree from Ghent University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
SUTRO BIOPHARMA, INC. 0,01 % | 08/07/2025 | 1.606 ( 0,01 % ) | 46 943 $ | 31/05/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| SUTRO BIOPHARMA, INC. | Corporate Officer/Principal | 01/12/2025 |
Limburgse Reconversie Maatschappij NV
Limburgse Reconversie Maatschappij NV Investment ManagersFinance LRM invests in companies located in Belgium. The firm targets companies operating in broad range of sectors and industries. It provides financing for seed, early, growth and mezzanine transactions. | Inversor de Capital Privado | 01/07/2017 |
GenEdit, Inc.
GenEdit, Inc. BiotechnologyHealth Technology Develops next generation therapeutics for genetic diseases | Corporate Officer/Principal | - |
Amakem NV
Amakem NV Medical/Nursing ServicesHealth Services Operates as a clinical stage ophthalmology company that provides treatments for serious eye conditions | Director/Miembro de la Junta | - |
Apitope International NV
Apitope International NV BiotechnologyHealth Technology Develops therapeutic vaccines | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
Sutro Biopharma, Inc.
Sutro Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new products in protein vaccines and therapeutics | Health Technology |
Imperial College London
Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Limburgse Reconversie Maatschappij NV
Limburgse Reconversie Maatschappij NV Investment ManagersFinance LRM invests in companies located in Belgium. The firm targets companies operating in broad range of sectors and industries. It provides financing for seed, early, growth and mezzanine transactions. | Finance |
Ghent University
Ghent University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Apitope International NV
Apitope International NV BiotechnologyHealth Technology Develops therapeutic vaccines | Health Technology |
Complix NV
Complix NV Pharmaceuticals: MajorHealth Technology Engages in the development of biopharmaceutical | Health Technology |
Amakem NV
Amakem NV Medical/Nursing ServicesHealth Services Operates as a clinical stage ophthalmology company that provides treatments for serious eye conditions | Health Services |
GenEdit, Inc.
GenEdit, Inc. BiotechnologyHealth Technology Develops next generation therapeutics for genetic diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.